サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676228

無痛性甲状腺炎の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Silent Thyroiditis Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 139 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
無痛性甲状腺炎の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 139 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

無痛性甲状腺炎の世界市場規模は、2024年の27億8,000万米ドルから2033年には49億2,000万米ドルに成長し、2026～2033年の予測期間中に6.54％の堅調な年間平均成長率（CAGR）を示すと予測されます。

無痛性甲状腺炎市場は、甲状腺疾患に対する認識の高まりと、効果的な管理戦略の必要性によって成長する見込みです。甲状腺の無痛性炎症を特徴とする無痛性甲状腺炎は、一過性の甲状腺機能亢進症に続いて甲状腺機能低下症を引き起こす可能性があります。この疾患に対する認識が医療プロバイダーや患者の間で高まるにつれ、診断ツールや治療オプションに対する需要が高まることが予想されます。市場には、甲状腺機能検査、画像診断、副腎皮質ステロイドや甲状腺ホルモン補充療法などの治療オプションなど、さまざまな製品が含まれます。

技術の進歩は、診断技術の革新が甲状腺評価の精度とスピードを高めることで、沈黙性甲状腺炎市場を大きく形成しています。超音波検査や核医療検査などの先進的画像診断技術の開発により、沈黙性甲状腺炎の診断能力が向上し、他の甲状腺疾患との鑑別が可能になっています。さらに、遠隔医療と遠隔モニタリングソリューションの統合により、甲状腺疾患のタイムリーな診断と管理が容易になり、患者が適切な治療を受けられるようになっています。市場が進化を続ける中、診断と治療サービスの強化のために研究開発を優先する企業が競合を獲得する可能性が高いです。

さらに、無痛性甲状腺炎市場は、甲状腺管理におけるエビデンスによる実践を推進する医療機関の臨床ガイドラインや勧告の影響をますます受けるようになっています。医療システムが甲状腺疾患の診断と治療に標準化されたプロトコルを採用するにつれて、信頼性が高く効果的なソリューションに対する需要は高まり続けると考えられます。この傾向は、新規治療アプローチの探求と既存治療法の改善を目的とした研究イニシアティブへの投資を促進しています。患者中心のケアと生活の質への注目が高まるにつれ、無痛性甲状腺炎の効果的な管理戦略へのニーズは拡大し、臨床ニーズに合致した製品を提供する企業は、この重要な市場で成功を収めることができます。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています。

市場概要：市場概要：定義、分類、産業の現状を含む市場の詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 無痛性甲状腺炎産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 世界の無痛性甲状腺炎市場分析：診断検査別

  • 診断検査別概要
  • 診断検査別過去・予測データ分析
  • 甲状腺機能検査
  • 甲状腺抗体検査
  • 超音波検査
  • 生検

第6章 世界の無痛性甲状腺炎市場分析：治療別

  • 治療別概要
  • 治療別過去・予測データ分析
  • 抗炎症薬
  • 抗うつ薬
  • ホルモン補充療法
  • 放射性ロジン治療

第7章 世界の無痛性甲状腺炎市場分析：患者タイプ別

  • 患者タイプ別概要
  • 患者タイプ別過去・予測データ分析
  • 成人
  • 小児
  • 妊婦
  • 産後女性

第8章 世界の無痛性甲状腺炎市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 無痛性甲状腺炎企業の競合情勢

  • 無痛性甲状腺炎市場競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • AstraZeneca Pic
  • GiaxoSmilhiine Plc
  • Bayer AG
  • Sanofi S.A.
  • Novo Nordisk A'S
  • Boeing Ingelheim GmbH
  • Novartis AG
  • Bof Laboralores Inc.
  • Pizer Inc.
  • Merck & Co Inc.
  • Ef Lily And Company
  • Amgen Inc.
  • Johnson & Johnson
  • Teva Phamaceutial Industries Ld
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Diagnostic Test (USD MN)
  • Thyroid Function Tests Market Sales By Geography (USD MN)
  • Thyroid Antibodies Tests Market Sales By Geography (USD MN)
  • Ultrasound Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Analysis By Treatment (USD MN)
  • Antiinflammatory Medications Market Sales By Geography (USD MN)
  • Anticepressants Market Sales By Geography (USD MN)
  • Hormone Replacement Therapy Market Sales By Geography (USD MN)
  • Radioactive lodine Treatment Market Sales By Geography (USD MN)
  • Analysis By Patient Type (USD MN)
  • Adults Market Sales By Geography (USD MN)
  • Children Market Sales By Geography (USD MN)
  • Pregnant Women Market Sales By Geography (USD MN)
  • Postpartum Women Market Sales By Geography (USD MN)
  • Global Silent Thyroiditis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Silent Thyroiditis Report
  • Market Research Process
  • Market Research Methodology
  • Global Silent Thyroiditis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Diagnostic Test
  • Market Attractiveness Analysis By Treatment
  • Market Attractiveness Analysis By Patient Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Diagnostic Test (USD MN)
  • Thyroid Function Tests Market Sales By Geography (USD MN)
  • Thyroid Antibodies Tests Market Sales By Geography (USD MN)
  • Ultrasound Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment (USD MN)
  • Antiinflammatory Medications Market Sales By Geography (USD MN)
  • Anticepressants Market Sales By Geography (USD MN)
  • Hormone Replacement Therapy Market Sales By Geography (USD MN)
  • Radioactive lodine Treatment Market Sales By Geography (USD MN)
  • Global Market Analysis By Patient Type (USD MN)
  • Adults Market Sales By Geography (USD MN)
  • Children Market Sales By Geography (USD MN)
  • Pregnant Women Market Sales By Geography (USD MN)
  • Postpartum Women Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11216702

Global Silent Thyroiditis Market size is anticipated to grow from USD 2.78 Billion in 2024 to USD 4.92 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.54% during the forecast period of 2026 to 2033.

The Silent Thyroiditis market is set for growth, driven by the increasing recognition of thyroid disorders and the need for effective management strategies. Silent thyroiditis, characterized by painless inflammation of the thyroid gland, can lead to transient hyperthyroidism followed by hypothyroidism. As awareness of this condition grows among healthcare providers and patients, the demand for diagnostic tools and therapeutic options is expected to rise. The market encompasses a range of products, including thyroid function tests, imaging modalities, and treatment options such as corticosteroids and thyroid hormone replacement therapy.

Technological advancements are significantly shaping the Silent Thyroiditis market, with innovations in diagnostic technologies enhancing the accuracy and speed of thyroid assessments. The development of advanced imaging techniques, such as ultrasound and nuclear medicine scans, is improving the ability to diagnose silent thyroiditis and differentiate it from other thyroid disorders. Additionally, the integration of telemedicine and remote monitoring solutions is facilitating timely diagnosis and management of thyroid conditions, ensuring that patients receive appropriate care. As the market continues to evolve, companies that prioritize research and development to enhance their diagnostic and therapeutic offerings will likely gain a competitive edge.

Moreover, the Silent Thyroiditis market is increasingly influenced by clinical guidelines and recommendations from healthcare organizations that promote evidence-based practices in thyroid management. As healthcare systems adopt standardized protocols for diagnosing and treating thyroid disorders, the demand for reliable and effective solutions will continue to rise. This trend is driving investment in research initiatives aimed at exploring novel treatment approaches and improving existing therapies. As the focus on patient-centered care and quality of life grows, the need for effective management strategies for silent thyroiditis will expand, positioning companies that align their offerings with clinical needs for success in this vital market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Diagnostic Test

  • Thyroid Function Tests
  • Thyroid Antibodies Tests
  • Ultrasound
  • Biopsy

By Treatment

  • Antiinflammatory Medications
  • Anticepressants
  • Hormone Replacement Therapy
  • Radioactive lodine Treatment

By Patient Type

  • Adults
  • Children
  • Pregnant Women
  • Postpartum Women
  • COMPANIES PROFILED
  • AstraZeneca pic
  • GiaxoSmilhiine plc
  • Bayer AG
  • Sanofi S.A.
  • Novo Nordisk A'S
  • Boeing Ingelheim GmbH
  • Novartis AG
  • bof Laboralores Inc.
  • Pizer Inc.
  • Merck & Co Inc.
  • Ef Lily and Company
  • Amgen Inc.
  • Johnson & Johnson
  • Teva Phamaceutial Industries Ld.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. SILENT THYROIDITIS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Diagnostic Test
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By Patient Type
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY DIAGNOSTIC TEST

  • 5.1. Overview By Diagnostic Test
  • 5.2. Historical and Forecast Data Analysis By Diagnostic Test
  • 5.3. Thyroid Function Tests Historic and Forecast Sales By Regions
  • 5.4. Thyroid Antibodies Tests Historic and Forecast Sales By Regions
  • 5.5. Ultrasound Historic and Forecast Sales By Regions
  • 5.6. Biopsy Historic and Forecast Sales By Regions

6. GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY TREATMENT

  • 6.1. Overview By Treatment
  • 6.2. Historical and Forecast Data Analysis By Treatment
  • 6.3. Antiinflammatory Medications Historic and Forecast Sales By Regions
  • 6.4. Anticepressants Historic and Forecast Sales By Regions
  • 6.5. Hormone Replacement Therapy Historic and Forecast Sales By Regions
  • 6.6. Radioactive lodine Treatment Historic and Forecast Sales By Regions

7. GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY PATIENT TYPE

  • 7.1. Overview By Patient Type
  • 7.2. Historical and Forecast Data Analysis By Patient Type
  • 7.3. Adults Historic and Forecast Sales By Regions
  • 7.4. Children Historic and Forecast Sales By Regions
  • 7.5. Pregnant Women Historic and Forecast Sales By Regions
  • 7.6. Postpartum Women Historic and Forecast Sales By Regions

8. GLOBAL SILENT THYROIDITIS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE SILENT THYROIDITIS COMPANIES

  • 9.1. Silent Thyroiditis Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF SILENT THYROIDITIS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. AstraZeneca Pic
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. GiaxoSmilhiine Plc
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bayer AG
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Sanofi S.A.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Novo Nordisk A'S
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Boeing Ingelheim GmbH
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Novartis AG
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bof Laboralores Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Pizer Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Merck & Co Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Ef Lily And Company
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Amgen Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Johnson & Johnson
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Teva Phamaceutial Industries Ld
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies